GlassScriptPhysician profile
Andrew H Bishop
NPI 1063423341
$6,999.18
in general payments reported to CMS, 2019-2025
38 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $157 · 2021: $714 · 2022: $1,008 · 2023: $1,303 · 2024: $1,436 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,107.61 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $770.69 | 2019-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $605.65 | 2019-2025 | Camzyos, Eliquis |
| Philips North America LLC | $459.20 | 2022-2023 | |
| Medtronic, INC. | $407.98 | 2021-2025 | Cobalt Dr Mri Surescan, Corevalve Evolut R |
| Boston Scientific Corporation | $403.83 | 2021-2025 | Watchman, Eluvia, Bodyguardian |
| Shockwave Medical, INC | $400.30 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $337.20 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $243.28 | 2019-2024 | Xarelto |
| Abbott Laboratories | $219.70 | 2021-2025 | Optis, Mitraclip |
| Novartis Pharmaceuticals Corporation | $196.66 | 2019-2025 | |
| Baxter Healthcare | $191.94 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Medtronic Vascular, INC. | $167.00 | 2019-2020 | |
| Pfizer INC. | $165.00 | 2019-2025 | |
| Novo Nordisk INC | $135.58 | 2024-2025 | Wegovy, Ozempic |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $114.16 | 2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $107.09 | 2019-2023 | |
| Chiesi USA, INC. | $104.88 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.17 | 2019-2025 | Jardiance |
| Biotronik INC. | $100.85 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $78.79 | 2022-2025 | Lifevest |
| Stryker Corporation | $78.38 | 2025 | Flowtriever, Artix Mt |
| Astrazeneca Pharmaceuticals LP | $70.11 | 2019-2024 | Farxiga |
| Inspire Medical Systems, INC. | $65.52 | 2023 | Inspire |
| Merck Sharp & Dohme LLC | $57.72 | 2021-2024 | Verquvo |
| Braemar Manufacturing, LLC | $44.72 | 2019 | |
| Atricure, INC. | $43.20 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Amgen INC. | $30.72 | 2023-2025 | Repatha, Repatha |
| Terumo Medical Corporation | $29.65 | 2021-2024 | Angio-Seal, Glidewire |
| Cardinal Health 200 LLC | $24.84 | 2021 | |
| Teleflex LLC | $22.75 | 2023 | Vascband |
| Actelion Pharmaceuticals US, INC. | $20.71 | 2019 | |
| Masimo Corporation | $17.33 | 2023 | Set and Rainbow Set, Patient Safetynet System |
| Lundbeck LLC | $17.22 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $14.99 | 2019 | |
| Gilead Sciences, INC. | $13.72 | 2019 | |
| Angiodynamics, INC. | $13.31 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.